Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03617939 · ClinicalTrials.gov registry record
A Lifetime Partnership With Patients Who Have or May be at Risk of Having Cancer
A clinical trial of Cancer Risk, sponsored by University of Colorado, Denver.
- Recruiting
- Registry status
- 20,000
- Enrollment target
- 6
- Study locations
NCT03617939 is a study of Cancer Risk that is actively recruiting participants, run by University of Colorado, Denver. The registered enrollment target is 20,000 participants, above the 11,171-participant average among 7 other Cancer Risk trials with a reported enrollment target (79% higher). The trial reports 6 study locations across 1 state.
The verdict
NCT03617939, a study of Cancer Risk, is actively recruiting participants, sponsored by University of Colorado, Denver.
- RECRUITING
- Registry status
- 20,000 participants
- Enrollment target
- 6
- Study locations
Study Summary
This is not a treatment study. The overall objective is to develop an improved standard of care through studying blood, tissue, biological, etc. samples, that patients have allowed researchers to procure.
Conditions Studied
Interventions
- OTHER Survey Assessments
- PROCEDURE Biospeciman Collection
- OTHER Medical Chart Reviews
Study Locations (6)
Colorado
- University of Colorado Hospital - Aurora
- UCHealth Memorial Hospital Central - Colorado Springs
- UCHealth Memorial Hospital North - Colorado Springs
- Cherry Creek Medical Center - Denver
- UCHealth Poudre Valley Health System - Fort Collins
- Highlands Ranch Medical Center - Highlands Ranch
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20,000 participants |
| Start Date | 2015-09-16 |
| Est. Completion | 2037-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03617939
The ClinicalTrials.gov registry entry for NCT03617939 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 20,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 11,171-participant average among 7 other Cancer Risk trials with a reported enrollment target (79% higher). The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cancer Risk appearing as the primary indexed condition, and to 3 interventions - of which Survey Assessments is the first listed.
NCT03617939 reports 6 study locations spanning 1 distinct geographic area - top geographies include Colorado.
Frequently Asked Questions
What is clinical trial NCT03617939 about?
NCT03617939 is a clinical study titled "A Lifetime Partnership With Patients Who Have or May be at Risk of Having Cancer". This is not a treatment study. The overall objective is to develop an improved standard of care through studying blood, tissue, biological, etc. samples, that patients have allowed researchers to procure.
What is the current status of trial NCT03617939?
This trial is currently recruiting. The enrollment target is 20,000 participants. The study started on 2015-09-16. Estimated completion is 2037-09.
What conditions does trial NCT03617939 study?
This clinical trial studies the following conditions: Cancer Risk.
What interventions are being tested in trial NCT03617939?
The interventions under investigation include: Survey Assessments (OTHER), Biospeciman Collection (PROCEDURE), Medical Chart Reviews (OTHER).
Who is sponsoring clinical trial NCT03617939?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03617939 being conducted?
This trial has 6 study locations across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer Risk
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Mirai-MRI: Validation of AI Models for Breast Cancer Risk
RECRUITING · NA
-
Total Cancer Care Protocol: A Lifetime Partnership With Patients Who Have or May be at Risk of Having Cancer
RECRUITING
-
Norris ORIEN Total Cancer Care
RECRUITING
-
InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer
RECRUITING
-
Morehouse Total Cancer Care Protocol
RECRUITING
-
CanScan; Community-based Registry to Assess, Address and advaNce SCreening for cANcer Prevention and Management
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.